Abbott announce Lingo to get full rollout in US in 2025.
This month, Abbott's Lingo was named as an honoree in the Digital Health category at CES (the annual US Consumer Electronics Show) recognising outstanding design and engineering. Lingo is the company's first biowearable aimed at the nutrition/wellness market and is based on the FreeStyle Libre 2 sensor.
In the US, the company have launched the product in a "restricted number of U.S. cities," with CEO Robert Ford reporting that the launch had exceeded expectations. A full expansion in this new market for Abbott lies ahead this year.
Disclaimer
Blogs and publications on this website are independent of any involvement by medtech companies or diabetes related charities. To ensure there is no bias, we do not accept any products, freebies or other material from any medtech provider. Except where credited otherwise, all materials are copyright ©️Love My Libre Ltd.
Love My Libre is not associated or affiliated with Abbott or FreeStyle Libre. Content here and on our website www.lovemylibre.com does not constitute medical advice or replace the relationship between you and healthcare professionals nor the advice you receive from them.
The author of this blog has type 1 diabetes and uses the FreeStyle Libre 2 which is provided on NHS prescription.
Leave a comment (all fields required). Please note, we are unable to respond to individual comments posted here.